beyond eprescribing
DESCRIPTION
Beyond ePrescribing. Factors Influencing Patient Safety in Medical Group Practices - September 26 th , 2007 AHRQ 2007: Improving Healthcare, Improving Live Larry Garber, M.D. – Medical Director for Informatics. Overview. Sources of Adverse Drug Events (ADE’s) in the ambulatory setting - PowerPoint PPT PresentationTRANSCRIPT
Beyond ePrescribingFactors Influencing Patient Safety in Medical Group Practices - September 26th, 2007AHRQ 2007: Improving Healthcare, Improving LiveLarry Garber, M.D. – Medical Director for Informatics
3
Overview
• Sources of Adverse Drug Events (ADE’s) in the ambulatory setting
• Reducing anticoagulant-related ADE’s• Future plans and barriers to reducing
ADE’s
SourceSource Total ADEsTotal ADEs Preventable Preventable (%)(%)
ER notesER notes 187187 37%37%
Hospital D/C’sHospital D/C’s 166166 35%35%
Computer Computer signalssignals
439439 34%34%
Electronic notesElectronic notes 565565 20%20%
Provider reportsProvider reports 168168 15%15%
Incident reportsIncident reports 55 60%60%
Sources of ADE Information
Field, TS et al. JAMIA 2004;52:1349-1354.
ADE Rates in the Ambulatory Setting
• ADEs:50 per 1000 person-years
• Preventable ADEs:14 per 1000 person-years (28%)
• Extrapolated to total Medicare 65+:1,446,949 ADEs per year438,046 preventable ADEs/year
• This is likely to be an underestimate
Gurwitz JH et al JAMA 2003;289:1107-1116
Financial Cost of ADE’s
0.00
500.00
1000.00
1500.00
2000.00
2500.00
12-11 10-9 8-7 6-5 4-3 2-1 1-2 3-4 5-6 7-8 9-10 11-12
Pre-Period Post-PeriodDay of the ADE
Weeks Before and After Date of ADE
Field TS, et al Medical Care 2005;43:1171-6
Financial Cost of ADE’s
• Increase in costs after an ADE: $1310Increase after a preventable ADE: $1983
• Extrapolated to 1000 adults age 65+Costs per year to treat preventable ADEs:$27,365
ADE Severity in the Ambulatory Setting
Fatal 0.6%
Life-threatening
11.1%
Serious 28.3%
LessSerious
60%
Severity & Preventability
Preventable52%
Of fatal & life-threatening events
Preventable20%
Of less serious events
Source of Errors
Other19%
Ordering39%
Monitoring42%
So where do you start?
11
12
13
14
Fallon Approach to Preventing ADE’s
• First target the Fatal & Life-Threatening preventable ADE’s Warfarin
• Then do a system-wide solution for the others
15
Preventing Warfarin ADE’s
• Ordering/Prescribing ePrescribing with drug interaction
checking Simplified referrals to Anticoagulation
Clinic
• Monitoring Converted Anticoagulation Clinic to Epic’s
EHR Simplified tracking of lab no-shows
16
17
Full dosing information is entered and available to be seen by all physicians and staff
Date of next INR is entered to trigger tickler system
18
INR Reminder automatically appears in the Anticoagulation Clinic In-basket on the patient’s due date, and doesn’t disappear until the due date is changed
INR Reminder automatically appears in the Anticoagulation Clinic In-basket on the patient’s due date, and doesn’t disappear until the due date is changed
Preventing Other ADE’s
• Use probabilistic risk assessment to: characterize systemic and behavioral
elements that increase of ADE’s during ordering/monitoring
identify potentially high-yield and likely-to-be-successful interventions
• Estimate likelihood that interventions at any given step would be successful in reducing errors at that step
• Select interventions for implementation19
Field TS et al AHRQ Grant # 1P20HS017109-01
Barriers to preventing ADE’s
• Most organizations don’t have EHR’s• ePrescribing doesn’t solve the
monitoring problem• Many EHR’s don’t currently have the
functionality to provide alerts for missing events without being in the context of a patient encounter
• MD compliance• Time and money required to build
interventions20
Summary:
• ADEs are common and often preventable
• Types of errors suggest focus on prescribing and monitoring Provision of information to physicians and
assistants at right time, right place…Use of automated tickler systems
• Costs are high and savings from preventing ADEs could partially offset costs of interventions
22
Questions?
Larry Garber, [email protected]
Special thanks to Terry Field, PhD and Jerry Gurwitz, M.D. for their assistance on this presentation and never-ending work to
study and prevent ADE’s